Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
HUMANISED BACULOVIRUS
Document Type and Number:
WIPO Patent Application WO2003016540
Kind Code:
A3
Abstract:
The invention relates to a genetically engineered baculovirus wherein said virus is engineered to target therapeutic agents to cells, typically cancer cells, for example prostate cancer cells.

More Like This:
JP2003219875NEW METHOD FOR PROMOTING VASCULARIZATION
WO/2005/105130NOVEL THERAPEUTIC USAGE OF FACTOR DERIVED FROM PIGMENT EPITHELIUM, CAPABLE OF INHIBITING NADPH OXIDASE ACTIVITY
JPH11506315[Title of the Invention] Gene therapy using a replication receptive targeted adenovirus vector
Inventors:
MAITLAND NORMAN (GB)
Application Number:
PCT/GB2002/003791
Publication Date:
December 18, 2003
Filing Date:
August 15, 2002
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
PROCURE THERAPEUTICS LTD (GB)
MAITLAND NORMAN (GB)
International Classes:
A61K35/76; A61K48/00; A61P35/00; C12N15/866; C12N7/00; (IPC1-7): C12N15/86; C07K14/005; A61K48/00
Domestic Patent References:
WO2000077233A22000-12-21
WO2000058470A12000-10-05
WO1994008022A11994-04-14
Foreign References:
DE19735593A11999-02-18
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: METHOD FOR REPAIRING A MUTANT RNA FROM A DNA WITH GENETIC DEFECTS AND FOR THE PROGRAMMED DEATH OF TU...

Next Patent: ENZYMATIC RESOLUTION OF T-BUTYL TAXANE DERIVATIVES